Results 151 to 160 of about 87,212 (241)

A UK healthcare professional survey on the islet autoantibody status of children and young people with pre‐stage 3 type 1 diabetes, on behalf of the British Society for Paediatric Endocrinology and Diabetes

Diabetic Medicine, EarlyView.
Rabbi Swaby, Tabitha Randell, Jane Bowen‐Morris, Colin Dayan, Daniela Elleri, Clare Hambling, Rebecca Martin, Sarinda Millar, Pooja Sachdev, Ambika Shetty, Julia Townson, Rachel E. J. Besser   +11 more
wiley   +1 more source

Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims In a six‐month randomized clinical trial, improved peripheral perfusion has been shown with liraglutide, associated with favourable vascular effects in people with type 2 diabetes and peripheral artery disease (PAD). We aimed to evaluate the durability of these benefits and to elucidate some mechanisms underlying liraglutide's effect over
Paola Caruso, Maria Ida Maiorino, Miriam Longo, Antonietta Maio, Lorenzo Scappaticcio, Nicole Di Martino, Carla Carbone, Mariluce Barrasso, Mariangela Caputo, Maurizio Gicchino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito   +12 more
wiley   +1 more source

Long‐term outcomes following alternative second‐line oral glucose‐lowering treatments: Results from the real‐world progression in type 2 diabetes mellitus United Kingdom (RAPIDS‐UK) model

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare long‐term complications for people with type 2 diabetes mellitus (T2DM) following second‐line treatment in routine practice with sulphonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i), or sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) added to metformin.
Orlagh U. Carroll, Patrick Bidulka, Anirban Basu, Amanda I. Adler, Stephen O'Neill, Andrew H. Briggs, David G. Lugo‐Palacios, Kamlesh Khunti, Richard Grieve   +8 more
wiley   +1 more source

Visual detection of abnormal hemoglobin with a procedure for glycated hemoglobin.

Clinical Chemistry, 1984
K Meek, N A Reddig, C P Howard
openaire   +3 more sources

Postnatal levels of glycated albumin and glycated hemoglobin A1c in mothers of large-for-gestational-age newborns. [PDF]

Front Pediatr
Železnik M, Trampuš Bakija A, Paro-Panjan D, Soltirovska-Šalamon A.   +3 more
europepmc   +1 more source

Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi, Harpreet S. Bhatia, Roger S. Blumenthal, Michael D. Shapiro, Anurag Mehta   +4 more
wiley   +1 more source

The Relationship Between Fibrinogen and Glycated Hemoglobin (HbA1c) in Diabetic Foot Ulcers. [PDF]

Cureus
Notu K, Kt J, Rajesh Lenin R, G NK, Kumar JS.   +4 more
europepmc   +1 more source

Cost‐effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi‐ethnic country in Asia

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic foot ulcers (DFUs) impose a vast health and economic burden on individuals and healthcare systems globally. We assessed the cost‐effectiveness of adding ON101, a novel treatment for accelerating wound healing, to general wound care (GWC) versus GWC alone for DFUs in Singapore, a multi‐ethnic country with increasing DFU prevalence
Hsuan‐Yu Su, Khong‐Yik Chew, Nicholas Graves, Huang‐Tz Ou   +3 more
wiley   +1 more source

Correlation Between Glycated Hemoglobin (HbA1c) Levels and Lipid Profile in Patients With Type 2 Diabetes Mellitus at a Tertiary Hospital in Saudi Arabia. [PDF]

Cureus
AlZeer I, AlBassam AM, AlFeraih A, AlMutairi A, AlAskar B, Aljasser D, AlRashed F, Alotaibi N, AlGhamdi S, AlRashed Z.   +9 more
europepmc   +1 more source

Real‐world evaluation of automated insulin delivery therapy in type 1 diabetes: A multicentre study across regional and metropolitan Queensland, Australia

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Background Automated insulin delivery (AID) systems, which integrate continuous glucose monitoring (CGM) with automated insulin dosing, have emerged as a transformative therapy. However, real‐world data on AID effectiveness, particularly in regional Australia, remain limited.
Akash Konantambigi, Wenyong Wang, Dylan Boggild, Arushi Rana, Larisa Syphers, Catherine Presley, Candice Cummins, Usman Malabu, Kate Hawke, Vasant Shenoy, Gaurav Puri, Harshal Deshmukh   +11 more
wiley   +1 more source